Curis Inc (NASDAQ:CRIS)
| 3.09 Delayed Data As of Jan 28 |  +0.02 / +0.65%Today’s Change | 2.92 Today|||52-Week Range 17.40 | -35.08% Year-to-Date |
Institutional investors purchased a net $220.8 thousand shares of CRIS during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 76.19% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Other institutional | 40.07% |
| Mutual fund holders | 36.11% |
| Individual stakeholders | 0.23% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2021 | CUTLER GROUP LP Bought 5.3 Thousand shares of Curis Inc |
| 1/06/2022 | MIRAE ASSET GLOBAL INVESTMENTS C... Bought 862.00 shares of Curis Inc |
| 12/31/2021 | SPIRE WEALTH MANAGEMENT LLC Bought 400.00 shares of Curis Inc |
Top 10 Owners of Curis Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| SSgA Funds Management, Inc. | 8.56% | 7,839,637 | 37,316,672 | +652,938 | +9.09% |
| Maverick Capital Ltd. | 8.27% | 7,577,489 | 36,068,848 | +5,607,753 | +284.70% |
| BlackRock Fund Advisors | 5.69% | 5,209,188 | 24,795,735 | +31,860 | +0.62% |
| The Vanguard Group, Inc. | 4.32% | 3,961,570 | 18,857,073 | -50,520 | -1.26% |
| Adage Capital Management LP | 4.26% | 3,900,000 | 18,564,000 | -1,200,000 | -23.53% |
| Lord, Abbett & Co. LLC | 3.81% | 3,493,565 | 16,629,369 | -90,409 | -2.52% |
| Polar Capital LLP | 3.51% | 3,214,700 | 15,301,972 | +1,214,700 | +60.74% |
| Candriam Belgium SA | 3.30% | 3,023,006 | 14,389,509 | +542,843 | +21.89% |
| Sio Capital Management LLC | 3.18% | 2,914,127 | 13,871,245 | -450,278 | -13.38% |
| Nantahala Capital Management LLC | 2.69% | 2,462,248 | 11,720,300 | +378,712 | +18.18% |
Top 10 Mutual Funds Holding Curis Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| SPDR S&P Biotech ETF | 6.50% | 5,949,798 | 28,321,038 | -95,940 | -1.59% |
| Polar Capital Funds Plc - Biotech... | 2.73% | 2,500,000 | 11,900,000 | +500,000 | +25.00% |
| Vanguard Total Stock Market Index... | 2.69% | 2,465,760 | 11,737,018 | 0 | 0.00% |
| Vanguard Institutional Total Stoc... | 2.69% | 2,465,760 | 11,737,018 | +1,862 | +0.08% |
| Biotech Growth Trust Plc (The) | 2.56% | 2,342,808 | 11,151,766 | +1,036,490 | +79.34% |
| Lord Abbett Developing Growth Fun... | 2.32% | 2,127,856 | 10,128,595 | -70,725 | -3.22% |
| iShares Russell 2000 ETF | 2.21% | 2,027,964 | 9,653,109 | -1,974 | -0.10% |
| Emerald Growth Fund | 1.21% | 1,106,553 | 5,267,192 | -59,622 | -5.11% |
| Vanguard Extended Market Index Fu... | 1.20% | 1,098,479 | 5,228,760 | +25,103 | +2.34% |
| Candriam Equities L - Oncology Im... | 0.94% | 863,585 | 4,110,665 | -614,147 | -41.56% |